| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d497dd8c2ca48d33ad86f914ea248be4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddb42b9c781eebb0917af73704342c24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09495871acf246e69685fdd43af6d68b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ae72dae0f8f4e880c75d4e1b35088c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f7762c642adf0c8ea87a0ae8c4d5ea2 |
| publicationDate |
2002-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0236620-A2 |
| titleOfInvention |
Ets-transcription factor related compound specific promoter and transactivators thereof |
| abstract |
The present invention relates to novel means for the treatment of diseases, in particular muscular diseases. The present invention relates to a nucleic acid capable of controlling the expression of a heterologous gene and of being selectively activated by an Ets-transcription factor related compound. The invention further relates to constructs, host cells comprising said nucleic acid, methods for recombinant expression of heterologous genes and methods for screening and identifying of candidate compounds having transcription regulatory activity using them. The invention additionally relates to a fusion protein for specifically activating said nucleic acid. The invention also relates to a kit comprising the nucleic acid and the fusion protein for recombinant expression of a heterologous gene. |
| priorityDate |
2000-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |